Search research articles
Contact Us
Filters
Showing results (61-70 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Heart Failure
|
August 9, 2005
The relevance of comorbidities for heart failure treatment in primary care: A European survey
Heidrun B Sturm, Flora M Haaijer-Ruskamp, Nic J Veeger, et al.
Journal of Psychosomatic Research
|
January 21, 2014
Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes
Sieta T de Vries, Joost C Keers, Rosalie Visser, et al.
Pharmacoepidemiology and Drug Safety
|
August 12, 2017
Application of the STOPP/START criteria to a medical record database
Katinka J Nauta, Feikje Groenhof, Jan Schuling, et al.
BMC Health Services Research
|
June 10, 2008
Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe?
Reginald Deschepper, Larissa Grigoryan, Cecilia Stålsby Lundborg, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 6, 2010
[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007]
Jaco Voorham, Flora M Haaijer-Ruskamp, Klaas van der Meer, et al.
Journal of Evaluation in Clinical Practice
|
May 26, 2006
Evidence-based treatment and quality of life in heart failure
Daniela Dobre, Cornelia H M van Jaarsveld, Adelita V Ranchor, et al.
Social Science & Medicine (1982)
|
September 9, 2006
Determinants for the adoption of angiotensin II receptor blockers by general practitioners
Jacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Plos One
|
October 8, 2015
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
Sieta T de Vries, Folgerdiena M de Vries, Thijs Dekker, et al.
European Journal of Clinical Pharmacology
|
January 25, 2006
Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines
Peter G M Mol, Petra Denig, Rijk O B Gans, et al.
British Journal of Clinical Pharmacology
|
April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?
Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Heart Failure
|
August 9, 2005
The relevance of comorbidities for heart failure treatment in primary care: A European survey
Heidrun B Sturm, Flora M Haaijer-Ruskamp, Nic J Veeger, et al.
Journal of Psychosomatic Research
|
January 21, 2014
Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes
Sieta T de Vries, Joost C Keers, Rosalie Visser, et al.
Pharmacoepidemiology and Drug Safety
|
August 12, 2017
Application of the STOPP/START criteria to a medical record database
Katinka J Nauta, Feikje Groenhof, Jan Schuling, et al.
BMC Health Services Research
|
June 10, 2008
Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe?
Reginald Deschepper, Larissa Grigoryan, Cecilia Stålsby Lundborg, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 6, 2010
[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007]
Jaco Voorham, Flora M Haaijer-Ruskamp, Klaas van der Meer, et al.
Journal of Evaluation in Clinical Practice
|
May 26, 2006
Evidence-based treatment and quality of life in heart failure
Daniela Dobre, Cornelia H M van Jaarsveld, Adelita V Ranchor, et al.
Social Science & Medicine (1982)
|
September 9, 2006
Determinants for the adoption of angiotensin II receptor blockers by general practitioners
Jacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Plos One
|
October 8, 2015
The Role of Patients' Age on Their Preferences for Choosing Additional Blood Pressure-Lowering Drugs: A Discrete Choice Experiment in Patients with Diabetes
Sieta T de Vries, Folgerdiena M de Vries, Thijs Dekker, et al.
European Journal of Clinical Pharmacology
|
January 25, 2006
Limited effect of patient and disease characteristics on compliance with hospital antimicrobial guidelines
Peter G M Mol, Petra Denig, Rijk O B Gans, et al.
British Journal of Clinical Pharmacology
|
April 20, 2011
Additional safety risk to exceptionally approved drugs in Europe?
Arna H Arnardottir, Flora M Haaijer-Ruskamp, Sabine M J Straus, et al.
Page
of 10